STEVEN YORDY: Open Payments
NPI 1710947197 · MUNCY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,241 in 123 payments from 21 companies in 2025. Trend: 2023 $2,635 · 2024 $2,386 · 2025 $2,241
Food & beverage: $2,241
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $475 |
| ABBVIE INC. | 21 | $339 |
| AstraZeneca Pharmaceuticals LP | 13 | $294 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $205 |
| Lilly USA, LLC | 8 | $123 |
| Exact Sciences Corporation | 6 | $119 |
| Amgen Inc. | 7 | $118 |
| PFIZER INC. | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| Phathom Pharmaceuticals, Inc. | 5 | $87 |
Products named: Ozempic, Kerendia, VRAYLAR, Wegovy, UBRELVY, BREZTRI, The Cologuard Plus Collection Kit, FARXIGA.
Industry payments across PA — which companies pay providers there.
